05/01/2020 12:00 AM EDT
Source: RAND Corporation. Published: 5/2020. This 15-page report discusses the need for more sustainable and scalable ways of incentivising pharmaceutical industry innovation in response to infectious disease threats to public health. The authors consider incentives for innovation both in the current context of the COVID-19 crisis, and in the context of preventing other emerging or re-emerging infectious disease threats from becoming crises further down the line. (PDF)
No hay comentarios:
Publicar un comentario